Sanguine

About:

Bridging the gap between patients and researchers

Top Investors: National Science Foundation, Catalio Capital Management, Mayo Clinic, StartUp Health, FundersClub

Description:

At Sanguine, our mission is to accelerate translational biomedical research by removing the barriers to patient participation. Through transparent communications, respectful patient support, and appropriate compensation, we keep patients engaged in the research process for a better patient experience and more impactful research biospecimens.

Total Funding Amount:

$12.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

2010-01-01

Contact Email:

learnmore(AT)sanguinebio.com

Founders:

Brian Neman, Carlyn Crisostomo, Gerald Lee, Kaley Zeitouni, Matthew Marple

Number of Employees:

101-250

Last Funding Date:

2023-10-31

IPO Status:

Private

Industries: